Board Meeting30 Sept 2026, 07:30 pm
Novartis India Board Meeting on Nov 3 to Approve Unaudited Financial Results
AI Summary
Novartis India Ltd has announced that its Board of Directors will convene on November 3, 2026. The primary agenda item for this meeting is to consider and approve the company's Unaudited Financial Results for the quarter and half-year ended September 30, 2026. In line with SEBI regulations, the trading window for designated persons will be closed from October 1, 2026, and will reopen 48 hours after the financial results are disclosed to the stock exchange. The company will also make this information available on its website.
Key Highlights
- Board meeting scheduled for November 3, 2026.
- To consider and approve Unaudited Financial Results.
- Results are for the quarter and half-year ended September 30, 2026.
- Trading window closure and reopening dates announced.
- Information to be available on the company website.
Price Impact
More from NOVARTIND